Alumis, Inc. (ALMS)
6.78
-0.04
(-0.59%)
USD |
NASDAQ |
Oct 23, 16:00
6.79
+0.01
(+0.15%)
After-Hours: 20:00
Alumis Price : 6.78 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 6.68 | 6.825 | 6.480 | 6.78 | 1.230M |
| Oct 22, 2026 | 6.72 | 6.945 | 6.655 | 6.82 | 1.504M |
| Oct 21, 2026 | 6.75 | 6.945 | 6.66 | 6.81 | 1.230M |
| Oct 20, 2026 | 6.33 | 6.725 | 6.25 | 6.70 | 1.535M |
| Oct 19, 2026 | 6.12 | 6.430 | 6.10 | 6.34 | 1.484M |
| Oct 16, 2026 | 6.31 | 6.31 | 6.01 | 6.12 | 2.497M |
| Oct 15, 2026 | 6.11 | 6.50 | 6.08 | 6.31 | 2.787M |
| Oct 14, 2026 | 6.47 | 6.55 | 6.015 | 6.06 | 2.298M |
| Oct 13, 2026 | 7.01 | 7.01 | 6.535 | 6.56 | 1.899M |
| Oct 12, 2026 | 7.13 | 7.31 | 6.97 | 7.06 | 1.601M |
| Oct 09, 2026 | 7.04 | 7.285 | 6.90 | 7.16 | 1.371M |
| Oct 08, 2026 | 6.66 | 7.02 | 6.61 | 6.97 | 2.853M |
| Oct 07, 2026 | 6.82 | 6.95 | 6.71 | 6.77 | 2.170M |
| Oct 06, 2026 | 6.89 | 6.95 | 6.64 | 6.93 | 1.746M |
| Oct 05, 2026 | 6.99 | 7.17 | 6.78 | 6.84 | 3.872M |
| Oct 02, 2026 | 7.28 | 7.31 | 6.635 | 6.85 | 2.625M |
| Oct 01, 2026 | 7.40 | 7.48 | 7.15 | 7.21 | 2.131M |
| Sep 30, 2026 | 7.35 | 7.555 | 7.15 | 7.39 | 1.403M |
| Sep 29, 2026 | 7.16 | 7.41 | 7.13 | 7.29 | 1.668M |
| Sep 28, 2026 | 7.10 | 7.22 | 6.83 | 7.16 | 2.245M |
| Sep 25, 2026 | 7.33 | 7.38 | 7.035 | 7.10 | 1.724M |
| Sep 24, 2026 | 7.43 | 7.45 | 7.22 | 7.29 | 2.605M |
| Sep 23, 2026 | 8.03 | 8.075 | 7.31 | 7.44 | 2.695M |
| Sep 22, 2026 | 8.01 | 8.14 | 7.67 | 8.11 | 2.525M |
| Sep 21, 2026 | 7.82 | 7.92 | 7.56 | 7.90 | 2.433M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Johnson & Johnson | 263.81 |
| Corcept Therapeutics, Inc. | 85.86 |
| Aclaris Therapeutics, Inc. | 3.75 |
| BioAge Labs, Inc. | 5.10 |
| ANI Pharmaceuticals, Inc. | 72.61 |
Price Related Metrics
| PS Ratio | 105.75 |
| Price to Book Value | 1.927 |
| Earnings Yield | -56.18% |
| Market Cap | 871.27M |